193 related articles for article (PubMed ID: 24010642)
21. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
22. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
23. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
[TBL] [Abstract][Full Text] [Related]
24. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
Laaribi AB; Zidi I; Hannachi N; Ben Yahia H; Chaouch H; Bortolotti D; Zidi N; Letaief A; Yacoub S; Boudabous A; Rizzo R; Boukadida J
J Viral Hepat; 2015 Oct; 22(10):835-41. PubMed ID: 25619305
[TBL] [Abstract][Full Text] [Related]
25. Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B.
Beggel B; Münk C; Däumer M; Hauck K; Häussinger D; Lengauer T; Erhardt A
J Viral Hepat; 2013 Dec; 20(12):882-9. PubMed ID: 24304458
[TBL] [Abstract][Full Text] [Related]
26. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro.
Bonvin M; Greeve J
J Gen Virol; 2007 Dec; 88(Pt 12):3270-3274. PubMed ID: 18024895
[TBL] [Abstract][Full Text] [Related]
27. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection.
Abe H; Ochi H; Maekawa T; Hatakeyama T; Tsuge M; Kitamura S; Kimura T; Miki D; Mitsui F; Hiraga N; Imamura M; Fujimoto Y; Takahashi S; Nakamura Y; Kumada H; Chayama K
Hepatol Res; 2009 Dec; 39(12):1159-68. PubMed ID: 19788695
[TBL] [Abstract][Full Text] [Related]
28. Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection.
Zhang P; Li F; Li N; Zhu Q; Yang C; Han Q; Chen J; Lv Y; Yu L; Wei P; Liu Z
Hum Immunol; 2014 Aug; 75(8):709-14. PubMed ID: 24768946
[TBL] [Abstract][Full Text] [Related]
29. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
[TBL] [Abstract][Full Text] [Related]
30. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
[TBL] [Abstract][Full Text] [Related]
31. Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H.
Köck J; Blum HE
J Gen Virol; 2008 May; 89(Pt 5):1184-1191. PubMed ID: 18420796
[TBL] [Abstract][Full Text] [Related]
32. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population.
Rebbani K; Ezzikouri S; Marchio A; Ababou M; Kitab B; Dejean A; Kandil M; Pineau P; Benjelloun S
Infect Genet Evol; 2014 Aug; 26():1-7. PubMed ID: 24797387
[TBL] [Abstract][Full Text] [Related]
33. G to A hypermutation of hepatitis B virus.
Noguchi C; Ishino H; Tsuge M; Fujimoto Y; Imamura M; Takahashi S; Chayama K
Hepatology; 2005 Mar; 41(3):626-33. PubMed ID: 15726649
[TBL] [Abstract][Full Text] [Related]
34. Human APOBEC3 Variations and Viral Infection.
Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
[TBL] [Abstract][Full Text] [Related]
35. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection.
Niro GA; Fontana R; Gioffreda D; Valvano MR; Lacobellis A; Facciorusso D; Andriulli A
Liver Int; 2005 Dec; 25(6):1175-81. PubMed ID: 16343069
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-Inducible Factor 1 Alpha-Mediated RelB/APOBEC3B Down-regulation Allows Hepatitis B Virus Persistence.
Riedl T; Faure-Dupuy S; Rolland M; Schuehle S; Hizir Z; Calderazzo S; Zhuang X; Wettengel J; Lopez MA; Barnault R; Mirakaj V; Prokosch S; Heide D; Leuchtenberger C; Schneider M; Heßling B; Stottmeier B; Wessbecher IM; Schirmacher P; McKeating JA; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwalder M
Hepatology; 2021 Oct; 74(4):1766-1781. PubMed ID: 33991110
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
[TBL] [Abstract][Full Text] [Related]
39. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.
Zhang T; Cai J; Chang J; Yu D; Wu C; Yan T; Zhai K; Bi X; Zhao H; Xu J; Tan W; Qu C; Lin D
Hum Mol Genet; 2013 Mar; 22(6):1262-9. PubMed ID: 23213177
[TBL] [Abstract][Full Text] [Related]
40. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
